Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Luzzago, Stefano"'
Autor:
Musi G; Department of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy., Mistretta FA; Department of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy., de Cobelli O; Department of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy., Bellin A; Department of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy., Vago GG; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy., Pravettoni G; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Applied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy., Bottero D; Department of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy., Piccinelli ML; Department of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy., Ferro M; Department of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy., Ivanova M; Division of Pathology, IEO European Institute of Oncology, IRCCS, Milan, Italy., Petralia G; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Precision Imaging and Research Unit, Department of Medical Imaging and Radiation Sciences, European Institute of Oncology (IEO), IRCCS, Milan, Italy., Marvaso G; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy., Jereczek-Fossa BA; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy., Bagnardi V; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy., Renne G; Division of Pathology, IEO European Institute of Oncology, IRCCS, Milan, Italy., Fusco N; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Division of Pathology, IEO European Institute of Oncology, IRCCS, Milan, Italy., Luzzago S; Department of Urology, European Institute of Oncology (IEO) IRCCS, Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2024 Feb 03; Vol. 61, pp. 1-9. Date of Electronic Publication: 2024 Feb 03 (Print Publication: 2024).
Autor:
Piccinelli ML; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy; Università degli Studi di Milano, Milan, Italy., Barletta F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Tappero S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, IRCCS Policlinico San Martino, Genova, Italy; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy., Cano Garcia C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Incesu RB; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Morra S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy., Scheipner L; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, Medical University of Graz, Graz, Austria., Tian Z; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada., Luzzago S; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, Milan, Italy., Mistretta FA; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, Milan, Italy., Ferro M; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy., Saad F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Hourani Center of Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan., Ahyai S; Department of Urology, Medical University of Graz, Graz, Austria., Longo N; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy., Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey., Chun FKH; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Terrone C; Department of Urology, IRCCS Policlinico San Martino, Genova, Italy; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy., Briganti A; Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., de Cobelli O; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, Milan, Italy., Musi G; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, Milan, Italy., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Publikováno v:
European urology focus [Eur Urol Focus] 2023 Sep; Vol. 9 (5), pp. 799-806. Date of Electronic Publication: 2023 Apr 04.
Autor:
Piccinelli ML; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada.; Department of Urology, IRCSS European Institute of Oncology, Milan, Italy.; Università degli Studi di Milano, Milan, Italy., Tappero S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada.; Department of Urology, IRCCS Policlinico San Martino, Genova, Italy.; Department of Surgical and Diagnostic Integrated Sciences, University of Genova, Genova, Italy., Cano Garcia C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada.; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Barletta F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada.; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Incesu RB; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada.; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Morra S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada.; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy., Scheipner L; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada.; Department of Urology, Medical University of Graz, Graz, Austria., Tian Z; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada., Luzzago S; Department of Urology, IRCSS European Institute of Oncology, Milan, Italy.; Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, Milan, Italy., Mistretta FA; Department of Urology, IRCSS European Institute of Oncology, Milan, Italy.; Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, Milan, Italy., Ferro M; Department of Urology, IRCSS European Institute of Oncology, Milan, Italy., Saad F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Hourani Center of Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan., Ahyai S; Department of Urology, Medical University of Graz, Graz, Austria., Longo N; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy., Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Department of Urology, Koc University Hospital, Istanbul, Turkey., Briganti A; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Chun FKH; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt am Main, Germany., Terrone C; Department of Urology, IRCCS Policlinico San Martino, Genova, Italy.; Department of Surgical and Diagnostic Integrated Sciences, University of Genova, Genova, Italy., de Cobelli O; Department of Urology, IRCSS European Institute of Oncology, Milan, Italy.; Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, Milan, Italy., Musi G; Department of Urology, IRCSS European Institute of Oncology, Milan, Italy.; Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, Milan, Italy., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2023 Jun 13; Vol. 53, pp. 109-115. Date of Electronic Publication: 2023 Jun 13 (Print Publication: 2023).
Autor:
Luzzago S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: stefanoluzzago@gmail.com., Palumbo C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Urology Unit, ASST Spedali Civili of Brescia, Brescia, Italy; Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Brescia, Italy., Rosiello G; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Knipper S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Pecoraro A; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy., Mistretta FA; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy., Tian Z; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada., Musi G; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy., Montanari E; Department of Urology, IRCCS Fondazione Ca' Granda-Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., Soulières D; Department of Hematology-Oncology, University of Montreal Hospital Centre (CHUM), Montreal, Quebec, Canada., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Saad F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada., Briganti A; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., de Cobelli O; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada.
Publikováno v:
European urology focus [Eur Urol Focus] 2021 May; Vol. 7 (3), pp. 598-607. Date of Electronic Publication: 2020 May 19.
Autor:
Palumbo C; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Urology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Brescia, Italy. Electronic address: palumbo.carlotta@gmail.com., Pecoraro A; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy., Knipper S; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Rosiello G; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy., Luzzago S; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy., Deuker M; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Hospital Frankfurt, Frankfurt, Germany., Tian Z; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Departments of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Simeone C; Urology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Brescia, Italy., Briganti A; Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy., Saad F; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada., Berruti A; Medical Oncology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Brescia, Italy., Antonelli A; Urology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Brescia, Italy., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada.
Publikováno v:
European urology focus [Eur Urol Focus] 2021 May; Vol. 7 (3), pp. 644-652. Date of Electronic Publication: 2020 May 23.
Autor:
Marvaso G; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Volpe S; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Pepa M; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy., Augugliaro M; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy., Corrao G; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Biffi A; National Centre of Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.; Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy., Zaffaroni M; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy., Bergamaschi L; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., La Fauci FM; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Unit of Medical Physics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Mistretta FA; Department of Urology, IEO European Institute of Oncology IRCCS, Milan, Italy., Luzzago S; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Urology, IEO European Institute of Oncology IRCCS, Milan, Italy., Cattani F; Unit of Medical Physics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Musi G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Urology, IEO European Institute of Oncology IRCCS, Milan, Italy., Petralia G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Radiology, IEO European Institute of Oncology IRCCS, Milan, Italy., Pravettoni G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Applied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology IRCCS, Milan, Italy., De Cobelli O; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Urology, IEO European Institute of Oncology IRCCS, Milan, Italy., Orecchia R; Scientific Directorate, IEO, European Institute of Oncology IRCCS, Milan, Italy., Jereczek-Fossa BA; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2021 Mar 16; Vol. 27, pp. 19-28. Date of Electronic Publication: 2021 Mar 16 (Print Publication: 2021).
Autor:
Vartolomei MD; Division of Urology, European Institute of Oncology, Milan, Italy; Department of Cell and Molecular Biology, University of Medicine and Pharmacy, Tirgu Mures, Romania., Matei DV; Division of Urology, European Institute of Oncology, Milan, Italy; Department of Urology, University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca, Romania., Renne G; Department of Laboratory and Pathology, European Institute of Oncology, Milan, Italy., Tringali VM; Division of Urology, European Institute of Oncology, Milan, Italy., Crisan N; Division of Urology, European Institute of Oncology, Milan, Italy; Department of Urology, University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca, Romania., Musi G; Division of Urology, European Institute of Oncology, Milan, Italy., Mistretta FA; Division of Urology, European Institute of Oncology, Milan, Italy., Russo A; Division of Urology, European Institute of Oncology, Milan, Italy., Cozzi G; Division of Urology, European Institute of Oncology, Milan, Italy., Cordima G; Division of Urology, European Institute of Oncology, Milan, Italy., Luzzago S; Division of Urology, European Institute of Oncology, Milan, Italy., Cioffi A; Division of Urology, European Institute of Oncology, Milan, Italy., Di Trapani E; Division of Urology, European Institute of Oncology, Milan, Italy., Catellani M; Division of Urology, European Institute of Oncology, Milan, Italy., Delor M; Division of Urology, European Institute of Oncology, Milan, Italy., Bottero D; Division of Urology, European Institute of Oncology, Milan, Italy., Imbimbo C; Division of Urology, University of Naples Federico II, Italy., Mirone V; Division of Urology, University of Naples Federico II, Italy., Ferro M; Division of Urology, European Institute of Oncology, Milan, Italy. Electronic address: matteo.ferro@ieo.it., de Cobelli O; Division of Urology, European Institute of Oncology, Milan, Italy; University of Milan, Milan, Italy.
Publikováno v:
European urology focus [Eur Urol Focus] 2019 Jul; Vol. 5 (4), pp. 636-641. Date of Electronic Publication: 2017 Oct 27.
Autor:
Erickson AM; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Department of Urology, Helsinki University Hospital, Helsinki, Finland; Department of Pathology, HUSLAB, Helsinki University Hospital, Helsinki, Finland. Electronic address: andrew.erickson@helsinki.fi., Luzzago S; Department of Urology, European Institute of Oncology, Milan, Italy; University of Milan, Milan, Italy., Semjonow A; Prostate Centre, Department of Urology, University Hospital Münster, Münster, Germany., Vasarainen H; Department of Urology, Helsinki University Hospital, Helsinki, Finland., Laajala TD; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Department of Mathematics and Statistics, University of Turku, Turku, Finland., Musi G; Department of Urology, European Institute of Oncology, Milan, Italy., de Cobelli O; Department of Urology, European Institute of Oncology, Milan, Italy; University of Milan, Milan, Italy., Mirtti T; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; Department of Pathology, HUSLAB, Helsinki University Hospital, Helsinki, Finland., Rannikko A; Department of Urology, Helsinki University Hospital, Helsinki, Finland; University of Helsinki, Helsinki, Finland.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2018 Sep; Vol. 1 (4), pp. 268-275. Date of Electronic Publication: 2018 May 15.
Autor:
Moschini M; Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI Milan, Italy; Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy. Electronic address: marco.moschini87@gmail.com., Bianchi M; Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI Milan, Italy., Gandaglia G; Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI Milan, Italy., Cucchiara V; Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI Milan, Italy., Luzzago S; Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI Milan, Italy., Pellucchi F; Department of Urology, AO Papa Giovanni XXIII, Bergamo, Italy., Damiano R; Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy., Serretta V; UO di Urologia, Policlinico Universitario 'Paolo Giaccone', Palermo, Italy., Briganti A; Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI Milan, Italy., Montorsi F; Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI Milan, Italy., Salonia A; Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI Milan, Italy., Colombo R; Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI Milan, Italy.
Publikováno v:
European urology focus [Eur Urol Focus] 2016 Apr; Vol. 2 (1), pp. 86-91. Date of Electronic Publication: 2015 Jun 03.